Boston Health Care For The Homeless Program

Boston Health Care For The Homeless Program, doing business as Mcinnis Health Group, is a nonprofit healthcare organization based in Boston, Massachusetts, that acts as a federal grant recipient and sub-recipient delivering primary care, mental health services, substance-use treatment, and care coordination to adults experiencing homelessness across the greater Boston area. The vendor operates primarily as a sub-recipient (60% of recent awards) on state and federal grants flowing through Massachusetts agencies and nonprofit prime grantees, with a smaller portfolio of direct prime grants from the Department of Health and Human Services.

The organization's customer concentration is heavily weighted to HHS. SAMHSA and the Health Resources and Services Administration account for approximately 79% of recent awards by count, with SAMHSA's Center for Mental Health Services and HRSA's Bureau of Primary Health Care dominating the funding pipeline. A single recent prime award from SAMHSA carries $400 thousand in potential value — a September 2026 project grant (CFDA 93.532, Centers for Mental Health Services Projects of Regional and National Significance) extending through September 2031 to implement the Zero Suicide Framework across BHCHP's federally qualified health center and health care for the homeless program, including standardized risk screening, cognitive behavioral therapy for suicide prevention, dialectical behavior therapy, and workforce training through clinical champions and continuous quality improvement. A second active prime award from HRSA's Bureau of Primary Health Care, dated December 2024 and completing November 2026, funds expansion of the organization's prison re-entry services (RISE — Reentry Initiatives for Support and Empowerment) to address health needs of individuals exiting incarceration to homelessness, with emphasis on chronic disease management, substance-use disorder treatment, and overdose prevention. A third completed prime award from HHS's Healthcare Systems Bureau (September 2023 through September 2026) supported infrastructure repair and equipment replacement, including heating and cooling system updates and patient bed replacement in the organization's recuperative care program.

As a sub-recipient, BHCHP provides clinical services — primary care, psychiatry, and medication-assisted treatment (opioid-assisted treatment) — to patients served by partner organizations including Casa Esperanza Inc., a local supportive housing nonprofit, under grants flowing through Massachusetts Department of Public Health and the Commonwealth of Massachusetts. The organization also serves as a sub-recipient on AmeriCorps grants awarded through Massachusetts Service Alliance, deploying 16 full-time AmeriCorps members to provide care coordination, overdose prevention, and health education to approximately 1,750 individuals experiencing homelessness annually, with support from 50 engaged volunteers. BHCHP participates as a clinical training site on NIH/NCI research grants administered through The General Hospital Corporation (tobacco cessation research) and Harvard College (housing-related cancer screening disparities research), and receives sub-awards under substance-use disorder and community health worker grants from state public health authorities.

The organization's award activity has grown unevenly — three awards in 2022, nine in 2023, ten in 2024 — then declined to five in 2025 and six in 2026. Three awards are scheduled to complete inside the next twenty-four months, creating recompete opportunity. BHCHP annually serves more than 11,000 individuals experiencing homelessness across more than 35 clinical sites in the greater Boston area and partners with shelter providers, public health departments, hospitals, correctional facilities including Suffolk County House of Corrections, and nonprofit housing organizations to deliver integrated medical care, behavioral health treatment, and support services. The organization has demonstrated expertise in hepatitis C cure and HIV viral load suppression among unsheltered populations and integrates evidence-based clinical protocols including harm reduction and person-centered care across its service delivery.